Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Summary 
Currently, Ian T. Clark is Chairman at X-Vax Technology, Inc., Chairman of Olema Pharmaceuticals, Inc., Chairman of Kyverna Therapeutics, Inc. and Vice President-Sales at IVAX Pharmaceuticals, Inc. Mr. Clark is also Member of TechNet and on the board of 6 other companies.

In his past career Ian T. Clark was Vice President-Sales & Marketing at Sanofi and Vice President-Sales for Aventis SA (a subsidiary of Sanofi), Director & Head-Commercial Operations at Genentech, Inc., Chief Operating Officer for Novartis Pharmaceuticals UK Ltd., General Manager of Novartis Pharmaceuticals Canada, Inc., Vice President-Sales & Marketing for IVAX LLC, Chief Marketing Officer at Roche Group and Member-BioFulcrum Board at The J. David Gladstone Institutes.

He received an undergraduate degree from The University of Southampton.


Current positions of Ian T. Clark 
NameTitle Since
Takeda Pharmaceutical Company Limited
(Pharmaceuticals)
Independent Director 2019
Guardant Health, Inc.
(Biotechnology & Medical Research)
Lead Independent Director 2017
Agios Pharmaceuticals, Inc.
(Biotechnology & Medical Research)
Independent Director 2016
Olema Pharmaceuticals, Inc.
(Biotechnology & Medical Research)
Chairman 2020
Gyroscope Therapeutics Holdings plc
(Biotechnology & Medical Research)
Non-Executive Director 2019
AVROBIO, Inc.
(Biotechnology & Medical Research)
Independent Director 2018
Corvus Pharmaceuticals, Inc.
(Biotechnology & Medical Research)
Independent Director 2017
X-Vax Technology, Inc. Chairman -
Kyverna Therapeutics, Inc. Chairman 2021
IVAX Pharmaceuticals, Inc. Vice President-Sales -
TechNet Member -


Holdings of Ian T. Clark 
NameEquities%Valuation
Agios Pharmaceuticals, Inc. (AGIO)
(Biotechnology & Medical Research)
4,9640.0084%233,308 USD
Olema Pharmaceuticals, Inc. (OLMA)
(Biotechnology & Medical Research)
00.0000%0 USD
AVROBIO, Inc. (AVRO)
(Biotechnology & Medical Research)
00.0000%0 USD
Corvus Pharmaceuticals, Inc. (CRVS)
(Biotechnology & Medical Research)
00.0000%0 USD


Ian T. Clark: Personal Network 
Most Read News 
11/23ELON MUSK : Tesla's Musk exercises more options, sells shares worth $1.05 billion
RE
11/30JACK DORSEY : Jack Dorsey chases crypto, fintech dream post Twitter
RE
12/05MUKESH AMBANI : Indian salesmen threaten supply disruptions in protest against Reliance
RE
11/24JAMIE DIMON : Jamie Dimon jokes that JPMorgan will outlast China's Communist Party
RE
12/01JACK DORSEY : Dorsey-led Square rebrands to Block in nod to blockchain
RE
12/03CATHIE WOOD : Cathie Wood's ARK Innovation fund hits 13-month low in tech selloff
RE
11/26ELON MUSK : Tesla decides against state aid for German battery plant as Musk opposes subsidies
RE
12/02ELON MUSK : Musk exercises more options, sells Tesla shares worth $1.01 billion
RE
11/23ERIK NORDSTROM : Nordstrom warns of supply shortages as holiday season approaches, shares plunge
RE
12/03DAVID HARRISON : U.S. Nonfarm Payrolls Up 210K in November, Unemployment Rate 4.2% -- Update
DJ
More news


© 2021 People and Ownership :   
Ian T. Clark : Connections